The CEO of Oramed Pharmaceuticals (ORMP), Nadav Kidron, says that the company is developing oral delivery solutions for drugs currently delivered via injection. It is also seeking to transform the treatment of diabetes through its proprietary lead candidate.
The Watch List
24 Mar 2021
SHARE
The Watch List
08 Feb 2022
Trading 360
23 Feb 2022
The Watch List
04 Jan 2022
Market On Close
23 Feb 2022
The Watch List
22 Feb 2022
Morning Trade Live
18 Mar 2022